One-step fabrication of an injectable antibacterial collagen hydrogel with in situ synthesized silver nanoparticles for accelerated diabetic wound healing

Developing antibacterial collagen-based wound dressings that target multidrug-resistant bacteria holds promise for healing diabetic wounds prone to infection, yet traditional approaches pose persistent challenges of cytotoxicity and uneconomical steps. To address these issues, we develop a biocompatible, eco-friendly, one-step cross-linking and reduction strategy, fabricating injectable antibacterial collagen hydrogels containing in situ-generated silver nanoparticles for diabetic wound care. By exposing the collagen-silver ion (Ag+) mixture to visible light, collagen-silver nanoparticle (Col I/AgNPs) hydrogels were one step created, eliminating the need for additional cross-linkers and toxic reducing agents. The synergistic interaction between collagen and silver ions was the first time investigated, revealing a pivotal redox reaction with a dual role that simultaneously initiated collagen cross-linking and reduced Ag+ to AgNPs. The resulting biocompatible Col I/AgNPs hydrogel was found to have multifunctional properties, exhibiting excellent injectability, enhanced biological activity, and outstanding broad-spectrum antimicrobial ability. Furthermore, animal experiments utilizing a diabetic full-thickness wound model demonstrated their excellent in vivo healing efficacies, capable of establishing efficient antibacterial barriers and serving as bioactive regenerative scaffolds. Our study proposes an innovative one-step approach to create injectable antibacterial collagen-silver nanoparticle hydrogels, highlighting their potential as advanced dressings for diabetic wound treatment and other biomedical applications.